Fangfei Qin graduated from the School of Pharmacy, Sun Yat-sen University in 2012. In 2020, she graduated from the Department of Chemical Biology, Peking University-Tsinghua Joint Center for Life Sciences. From 2022 to 2024, she conducted post-doctoral research in cell biology at the Massachusetts Institute of Technology / Whitehead Institute. Since 2025, she has been an associate professor at the School of Life Sciences, Tianjin University. Fangfei Qin has studied under Academician Xinzi Chen / Professor Xingshu Li from the direction of medicinal chemistry and asymmetric catalysis, Professor Peter Wipf, a well-known total synthetic organic chemist in the United States, Professor PengChen, a leader in chemical biology in China, a well-known scientist in the field of stem cells, a member of the American Academy of Sciences, one of the founders of the Whitehead Institute, and Professor Rudolf Jaenisch, a pioneer of transgenic animals. Dr. Qin has published many articles in Cell, Nat. Commun., JACS, Angew. Chem. and other journals so far.

Fangfei 's research integrates multidisciplinary fields such as organic chemistry, chemical biology, proteomics, genomics, molecular biology and stem cell biology, comprehensively integrates the two basic disciplines of chemistry and biology, and strives to promote the integrated development of proteomics and genomics. Explore the infinite possibilities for the development of precision medicine in the future.